Ann: MDR December 2017 Quarterly Report & Appendix 4C, page-5

They had to get something out this week. Looks like the quarterly was ready first.

I too would have assumed we'd hit 1M by the end of December.

The 2016 December quarterly quoted 600k users. With only 35k added in the last 3 months suggests they may be reaching saturation under their current model. EBOS has arrived just in time.

With the MOU waiting to go binding, the benefits with using EBOS to promote MDR will really only hit the bottom line in the EOFY Report. There's reference to a separate announcement once agreements are final. I'm now thinking February.

Despite the really good news, 25% increase in revenue from the last quarter, more PEP customers, more users, growing patient numbers per pharmacy and increased use of tap-t0-refill the market appears to be waiting for the agreement to be formalised and a detailed understanding of the terms, conditions and financial benefits that will come with EBOS (HPS, Zest, Terry White Chemart Pharmacies).

Also noticed the volume at 6c disappeared. Perhaps they want to sell higher and pulled their order or perhaps it expired as it was there for a couple weeks.